GlassScriptPhysician profile
Charonn Woods
NPI 1396109062
$11,792.85
in general payments reported to CMS, 2019-2025
24 companies · $640 in 2025
The $640 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $683 · 2021: $2,033 · 2022: $1,492 · 2023: $3,464 · 2024: $3,481 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,863 · Travel and Lodging: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,862.66 |
| Travel and Lodging | $722.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,214.71 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $2,104.36 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Accurian |
| Si-Bone, INC. | $1,290.93 | 2022-2024 | |
| Nevro Corp. | $1,133.78 | 2020-2024 | Senza |
| Painteq LLC | $814.01 | 2021-2024 | Painteq |
| Vertos Medical, INC. | $717.90 | 2022-2024 | Mild Device Kit |
| Boston Scientific Corporation | $518.75 | 2020-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept |
| Medtronic USA, INC. | $444.88 | 2020 | |
| Stryker Corporation | $316.46 | 2021-2025 | Mild Device Kit, Optablate |
| Mml US, INC. | $307.93 | 2024 | Reactiv8 |
| Spr Therapeutics, INC | $257.81 | 2023-2024 | Sprint Pns System |
| Nalu Medical, INC. | $189.05 | 2021-2022 | |
| Relievant Medsystems, INC. | $157.56 | 2023 | Intracept |
| Spinal Simplicity, LLC | $73.32 | 2024 | Ha Minuteman G3-R |
| Catalyst Orthoscience | $54.56 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $48.65 | 2022-2024 | Belbuca, Xtampza |
| Depuy Synthes Sales INC. | $25.44 | 2021 | |
| Arbor Pharmaceuticals, INC. | $23.10 | 2021-2022 | |
| Globus Medical, INC. | $21.22 | 2025 | Senza |
| Radius Health, INC. | $16.51 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.03 | 2025 | |
| Scilex Pharmaceuticals INC. | $15.68 | 2021 | |
| Grt US Holding, INC. | $15.11 | 2022 | |
| Bioventus LLC | $15.10 | 2025 | Gelsyn-3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charonn Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.